37528117|t|Mitochonic acid 5 attenuates age-related neuromuscular dysfunction associated with mitochondrial Ca2+ overload in Caenorhabditis elegans.
37528117|a|Mitochonic acid-5 ameliorates the pathophysiology of human mitochondrial-disease fibroblasts and Caenorhabditis elegans Duchenne muscular dystrophy and Parkinson's disease models. Here, we found that 10 muM MA-5 attenuates the age-related decline in motor performance, loss of muscle mitochondria, and degeneration of dopaminergic neurons associated with mitochondrial Ca2+ overload in C. elegans. These findings suggest that MA-5 may act as an anti-aging agent against a wide range of neuromuscular dysfunctions in metazoans.
37528117	0	17	Mitochonic acid 5	Chemical	MESH:C000605791
37528117	41	66	neuromuscular dysfunction	Disease	MESH:D009468
37528117	97	101	Ca2+	Chemical	-
37528117	138	155	Mitochonic acid-5	Chemical	MESH:C000605791
37528117	197	218	mitochondrial-disease	Disease	MESH:D028361
37528117	258	285	Duchenne muscular dystrophy	Disease	MESH:D020388
37528117	290	309	Parkinson's disease	Disease	MESH:D010300
37528117	345	349	MA-5	Chemical	-
37528117	422	434	mitochondria	Disease	MESH:C564971
37528117	440	476	degeneration of dopaminergic neurons	Disease	MESH:D009410
37528117	507	511	Ca2+	Chemical	-
37528117	564	568	MA-5	Chemical	-
37528117	624	650	neuromuscular dysfunctions	Disease	MESH:D009468
37528117	Negative_Correlation	MESH:C000605791	MESH:D009468
37528117	Negative_Correlation	MESH:C000605791	MESH:D010300
37528117	Negative_Correlation	MESH:C000605791	MESH:D020388
37528117	Negative_Correlation	MESH:C000605791	MESH:D028361

